Braskem S.A. filings document foreign-issuer current reports for a Brazilian publicly held petrochemical company with American depositary shares representing Class A preferred shares. Form 6-K disclosures cover production and sales reports, segment performance for Brazil/South America, the United States and Europe, and Mexico, and petrochemical spread information.
The filing record also includes governance and ownership materials, including board meeting minutes, executive officer elections, shareholders’ agreement disclosures, annual general meeting minutes, final voting maps, financial statement approvals, treasury-share information, and management or related-person trading reports filed under CVM disclosure rules.
Braskem S.A. (BAK) said it and certain holders and investment managers of its Senior Notes and Debentures have exchanged information and indicative, non-binding proposals concerning an updated capital-structure plan. After meetings involving Braskem, its main shareholders and the investors, the parties had not reached agreement on final restructuring terms. Braskem expects discussions to continue.
Braskem filed a petition for extrajudicial reorganization on August 24, 2026. The filed Plan had participation from unsecured creditors representing 39.6% of the claims subject to it. It provides for an Updated Plan to be submitted within 90 days of the petition and includes negotiation milestones. The agreement-in-principle milestone was most recently extended to October 30, 2026. The proposals and terms remain non-binding and subject to negotiation and agreement among Braskem, its main shareholders and the Signatory Creditors, as well as required governance approvals.
Braskem (BAK) disclosed two non-binding proposals for an updated out-of-court restructuring plan. After meetings with creditors and principal shareholders, neither proposal had been accepted and the parties had not reached agreement on restructuring terms. Discussions were expected to continue toward a milestone extended to October 30, 2026.
Both proposals contemplate an equity rights offering: US$2.25 billion in Braskem’s October 23, 2026 proposal and $2.25 billion in the investors’ October 24, 2026 proposal. Braskem’s proposal includes a US$1.2 billion backstop and a US$2.8 billion upfront debt-to-equity conversion; the investor proposal lists a $1.85 billion backstop and a $1.85 billion upfront conversion. Braskem’s proposal also includes up to US$0.5 billion in contingent equity and up to US$[0.5–1.0] billion in contingent debt conversion in June 2029. The investor proposal excludes contingent equity and lists up to $450 million of contingent debt conversion in June 2029. The indicative terms are subject to approvals and are not binding unless included in a confirmed plan and definitive agreements. Separate projections through 2035 are described as hypothetical and not guidance.
Braskem S.A. (BAK) furnished its October 2026 Code of Conduct, setting expectations for employees, officers, directors, interns and apprentices, as well as third parties acting for or doing business with the company. It calls for integrity, transparency and compliance, and states zero tolerance for corruption, including extortion and bribery.
The code requires due diligence on third parties and written agreements reflecting ethical and legal standards; prohibits facilitation payments and political contributions using Braskem resources or on its behalf; and bars harassment and discrimination. It sets expectations for workplace health, safety and environmental conduct, conflicts of interest, business courtesies, related-party dealings and competition. Braskem also says it maintains internal controls intended to provide reasonable assurance about external financial reporting and commits to accurate, timely investor communications. Employees are directed to report suspected violations in good faith through leaders, Compliance or the Ethics Line.
Braskem S.A. said it received notice from shareholder NSP Investimentos S.A. that successive sales of its Class A preferred shares reduced its stake to less than 5% of that class. As of October 19, 2026, NSP held 7,152,113 Class A preferred shares, representing approximately 2.07% of the class. NSP said its investment is for investment purposes and that it does not intend to change Braskem’s control or administrative structure.
Braskem S.A. (BAK) reported that FFI Fund Ltd., FYI Ltd. and Olifant Fund Ltd. filed an involuntary Chapter 11 petition on October 21, 2026, against Braskem America Finance Company, an indirect subsidiary whose stated sole purpose is raising and managing funds in international markets to finance the operating activities of Braskem and its subsidiaries.
According to the petition documents, the petitioning creditors hold beneficial interests in America Finance’s 7.125% Notes due 2041, with approximately US$272 million in principal, about 47% of the notes’ aggregate outstanding principal. America Finance’s indebtedness consists exclusively of those notes, with approximately US$589 million in principal. The petition relates only to America Finance and its indebtedness; Braskem and its subsidiaries, including entities subject to the ongoing extrajudicial reorganization in Brazil and Chapter 15 cases in the United States, are not listed as debtors.
Braskem S.A. reported 27 Class “A” preferred shares in treasury at both the opening and closing of September 2026. The section for trading during the month lists no intermediate operation.
Braskem S.A. (BAK) reported September 2026 securities-trading and holdings information for management and related persons, controlling shareholders, board members, the fiscal council, and technical or advisory bodies. The tables include securities issued by Braskem and Petrobras.
A consolidated Braskem table lists opening and closing balances of 438,761,574 common shares and 123,055,912 Class A preferred shares. Several sections state that no securities or derivatives transactions were executed; other sections contain securities quantities and monthly trading fields.
Braskem S.A. said the court handling its extrajudicial reorganization granted its processing and ratified a 120-day suspension of covered enforcement proceedings against the company and certain subsidiaries. The period accounts for the deduction of 60 days granted under an earlier decision awarding injunctive relief. The suspension also covers the applicable statute of limitations, related lawsuits and proceedings, bankruptcy petitions, and specified measures against assets, for creditors subject to the reorganization.
On September 22, 2026, the Public Prosecutor’s Office submitted an opinion recommending, among other matters, that Braskem be ordered to take no further actions to implement the restructuring of Braskem Idesa S.A.P.I. de C.V. and that a judicial administrator be appointed for Braskem. Braskem noted that the opinion is not a court decision. The company said it had become aware of a court decision addressing the opinion; that decision remained pending official publication, and Braskem was evaluating its consequences and next steps.
Braskem S.A. (BAK) said it was informed of a decision issued by the 2nd Bankruptcy and Judicial Reorganization Court of São Paulo in the extrajudicial reorganization proceeding involving the company and certain subsidiaries. Braskem has not yet been formally served, and the decision remains pending official publication. The company is assessing the consequences and next steps and said it will inform the market of material developments.
Braskem S.A. (BAK) furnished an update on its own securities and derivatives positions for August 2026, as required by Article 11 of CVM Resolution #44/2021. The company reports that the only operations with its securities and derivatives were those listed, involving Class “A” preferred shares held in treasury.
The report also reiterates that Braskem’s disclosures may include forward-looking statements subject to various risks and uncertainties, including references to a geological event in Alagoas and COVID-19, directing readers to its Form 20-F and subsequent Exchange Act reports for a more complete discussion of risk factors.